Showing results (341-350 of 358) with videos related to

Sort By:
Pageof 36
JAMA Oncology|September 23, 2018
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysisDaniel Y Wang, Joe-Elie Salem, Justine V Cohen, et al.
Breast Cancer Research : BCR|January 24, 2025
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])A DeMichele, A C Dueck, D Hlauschek, et al.
Cancer Research Communications|April 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast CancerElizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2023
Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanomaSelina K Wong, Steven M Blum, Xiaopeng Sun, et al.
Cancer Discovery|December 1, 2020
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic InterventionSpencer C Wei, Wouter C Meijers, Margaret L Axelrod, et al.
The Journal of Clinical Investigation|December 9, 2025
CD8+ T cells in the tumor microenvironment modulate response to endocrine therapy in breast cancerFabiana Napolitano, Yunguan Wang, Dhivya R Sudhan, et al.
Nature Communications|March 28, 2019
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancerLuigi Formisano, Yao Lu, Alberto Servetto, et al.
The New England Journal of Medicine|November 3, 2016
Fulminant Myocarditis with Combination Immune Checkpoint BlockadeDouglas B Johnson, Justin M Balko, Margaret L Compton, et al.
Nature Medicine|July 24, 2019
A case report of clonal EBV-like memory CD4<sup>+</sup> T cell activation in fatal checkpoint inhibitor-induced encephalitisDouglas B Johnson, Wyatt J McDonnell, Paula I Gonzalez-Ericsson, et al.
Science Translational Medicine|August 11, 2017
Genomic profiling of ER<sup>+</sup> breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistanceJennifer M Giltnane, Katherine E Hutchinson, Thomas P Stricker, et al.
Pageof 36